Stereotaxis (STXS) received U.S. Food and Drug Administration 510(k) clearance for its MAGiC Sweep catheter. The company said, “MAGiC Sweep is the world’s first robotically navigated high-density electrophysiology mapping catheter, representing a significant advancement in the technology available to diagnose and treat complex arrhythmia patients.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STXS:
